DRL launches of Progesterone Capsules in the US Market

Progesterone Capsules, 100 mg and 200 mg, are available in bottle count size of 100

Dr Reddy’s Laboratories (DRL) has launched Progesterone Capsules, 100 mg and 200 mg, a therapeutic equivalent generic version of Prometrium (Progesterone) Capsules in the US market, approved by the USFDA.

The Prometrium brand and generic had US sales of approximately $153 million MAT for the most recent twelve months ending in February 2017 according to IMS Health.

DRL’s Progesterone Capsules, 100 mg and 200 mg, are available in bottle count size of 100.